发明公开
- 专利标题： HALOALLYLAMINE INHIBITORS OF SSAO/VAP-1 AND USES THEREFOR
- 专利标题（中）： SSAO / VAP-1的卤代丙烯酰胺抑制剂及其应用
-
申请号： EP08851514.3申请日： 2008-11-19
-
公开(公告)号： EP2222160A2公开(公告)日： 2010-09-01
- 发明人: MCDONALD, Ian, Alexander , TURNER, Craig, Ivan , DEODHAR, Mandar , FOOT, Jonathan, Stuart
- 申请人： Pharmaxis Ltd.
- 申请人地址： Unit 2 10 Rodborough Road Frenchs Forest, NSW 2085 AU
- 专利权人： Pharmaxis Ltd.
- 当前专利权人： Pharmaxis Ltd.
- 当前专利权人地址： Unit 2 10 Rodborough Road Frenchs Forest, NSW 2085 AU
- 代理机构： Lord, Hilton David
- 优先权： US989634P 20071121
- 国际公布： WO2009066152 20090528
- 主分类号： A01N33/02
- IPC分类号： A01N33/02
摘要：
The present invention is related to the preparation and pharmaceutical use of novel haloallylamine derivatives as SSAO/VAP-1 inhibitors having the structure of Formula I, as defined in the specification:(I). The invention also relates to methods of using invention compounds, or pharmaceutically acceptable salt or derivatives thereof, for the treatment of a variety of indications, e.g., inflammatory diseases.
公开/授权文献
- EP2222160B1 HALOALLYLAMINE INHIBITORS OF SSAO/VAP-1 AND USES THEREFOR 公开/授权日：2015-03-18
信息查询
